China Regenerative Medicine International Limited (HKG:8158)
0.3850
-0.0150 (-3.75%)
Jun 1, 2026, 3:12 PM HKT
HKG:8158 Market Cap
HKG:8158 has a market cap or net worth of 117.14 million as of June 1, 2026. Its market cap has decreased by -3.75% in one year.
Market Cap
117.14M
Enterprise Value
160.27M
Revenue
72.06M
Ranking
n/a
PE Ratio
4.26
Stock Price
0.39
Market Cap Chart
Since July 18, 2001, HKG:8158's market cap has increased from 67.20M to 117.14M, an increase of 74.31%. That is a compound annual growth rate of 2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 121.70M | -4.76% |
| Dec 31, 2025 | 127.79M | 42.37% |
| Dec 31, 2024 | 89.75M | -46.36% |
| Dec 29, 2023 | 167.34M | -47.18% |
| Dec 30, 2022 | 316.83M | -60.36% |
| Dec 31, 2021 | 799.20M | -50.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 1.14B |
| Sunho Biologics | 970.43M |
| 3D Medicines | 836.76M |
| Wuhan YZY Biopharma | 833.55M |
| Brii Biosciences | 830.08M |
| JW (Cayman) Therapeutics Co. | 803.67M |
| Shanghai Bio-heart Biological Technology | 735.12M |
| Transcenta Holding | 674.10M |